Published: Sat, January 13, 2018
People | By Leon Thompson

Seattle Genetics (NASDAQ:SGEN) Rating Reiterated by Oppenheimer

The stock increased 1.93% or $0.31 during the last trading session, reaching $16.4. The total number of shares traded in the last 90-day period is 136,314. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since January 13, 2017 and is uptrending. It has outperformed by 54.54% the S&P500. (MD) by 18.02% based on its latest 2017Q3 regulatory filing with the SEC. Group One Trading Ltd Partnership holds 422 shares or 0% of its portfolio. JGP Global Gestao de Recursos Ltda. now owns 20,603 shares of the biotechnology company's stock worth $1,121,000 after acquiring an additional 969 shares during the last quarter. The stock increased 1.24% or $0.44 during the last trading session, reaching $35.97.

Bnp Paribas Arbitrage Sa, which manages about $40924.49B US Long portfolio, upped its stake in Liberty Media Corp Delaware by 103 shares to 2,774 shares, valued at $105.66M in 2017Q3, according to the filing.

Capital International Sarl increased its stake in Seattle Genetics Inc (SGEN) by 51.62% based on its latest 2017Q3 regulatory filing with the SEC. It has outperformed by 58.98% the S&P500. United States Lime & Minerals, Inc. The stock has a market cap of $7,450.00, a price-to-earnings ratio of -59.52 and a beta of 2.37.

Several equities analysts have recently issued reports on the company.

Among 7 analysts covering Regulus Therapeutics (NASDAQ:RGLS), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 53% are positive. Maxim Group maintained the shares of CUTR in report on Thursday, July 13 with "Buy" rating. On Monday, June 19 the stock rating was maintained by Needham with "Buy". The stock of Bloomin' Brands, Inc. (NYSE:LRN) has "Overweight" rating given on Wednesday, August 10 by First Analysis.

Teacher accused of telling black student he may be lynched
Agee-Bell has had her son pulled from Thole's class. "It was unbelievable (Nathan) was courageous enough to confront the teacher". Agee-Bell told Fox 19 she was shocked. "Today is a day where we can learn the importance of thinking before you speak", she said.

Since August 25, 2017, it had 0 buys, and 2 insider sales for $1.24 million activity. (NASDAQ:RGLS) has "Market Perform" rating given on Tuesday, June 28 by BMO Capital Markets.

The company's consensus rating on Reuter's scale slipped from 1.73 to 1.7 during a month. Insiders sold a total of 66,965 shares of company stock valued at $4,254,779 over the last three months.

Investors sentiment decreased to 1.22 in 2017 Q3. Its up 0.83, from 1.5 in 2017Q2. It is positive, as 36 investors sold AOS shares while 132 reduced holdings. 11 funds opened positions while 16 raised stakes. Royal Bank of Canada initiated coverage on shares of Seattle Genetics in a research report on Thursday, September 14th. Credit Suisse Ag reported 0% in K12 Inc. Rhenman Prtn Asset Ab has 0.09% invested in Regulus Therapeutics Inc. Ecor1 Capital Ltd Llc invested 0.87% in Regulus Therapeutics Inc. Jacobs Levy Equity Management Inc has 93,411 shares. (NYSE:LRN) for 153,500 shares. State Of Wisconsin Investment Board accumulated 18,684 shares. Millennium invested 0% of its portfolio in Regulus Therapeutics Inc. 37,051 were accumulated by Granite Investment Ptnrs Limited Liability Company. Ascend Cap Limited Liability Company invested in 164,648 shares or 0.34% of the stock. Blair William And Il reported 50,748 shares. Brown Advisory reported 33,938 shares. Winfield holds 0% or 40 shares. Therefore 39% are positive. The firm earned "Outperform" rating on Wednesday, November 4 by Raymond James. The stock has "Buy" rating by H.C. Wainwright on Friday, October 27. The firm earned "Hold" rating on Friday, June 2 by Oppenheimer. The firm has "Neutral" rating given on Wednesday, August 10 by PiperJaffray. The firm earned "Hold" rating on Wednesday, August 16 by Cantor Fitzgerald.

Another recent and important Cutera, Inc. On Friday, February 10 the stock rating was downgraded by Bank of America to "Underperform". (NASDAQ:SGEN) on Monday, June 19 with "Buy" rating. Seattle Genetics has a twelve month low of $45.31 and a twelve month high of $71.32. During the same period in the previous year, the company earned ($0.23) earnings per share. The institutional investor held 376,860 shares of the health care company at the end of 2017Q3, valued at $13.64M, down from 538,159 at the end of the previous reported quarter. The stock has "Hold" rating by Cowen & Co on Monday, August 14. The insider DRACHMAN JONATHAN G sold $475,414. SMITH ELIZABETH A sold 375,000 shares worth $7.80 million. (NASDAQ:SGEN) by 2.7% during the fourth quarter, Holdings Channel reports. The stock of Seattle Genetics, Inc. 60,000 shares were sold by JONES PAUL W, worth $3.24M on Thursday, August 3. $501,176 worth of stock was sold by SIMPSON TODD E on Wednesday, September 6.

Investors sentiment decreased to 1.13 in Q3 2017. Its up 0.20, from 0.94 in 2017Q2. It is negative, as 51 investors sold SGEN shares while 74 reduced holdings. 28 funds opened positions while 62 raised stakes. The business's quarterly revenue was up 27.3% compared to the same quarter last year. equities analysts anticipate that Seattle Genetics will post -0.93 EPS for the current year. (NASDAQ:SGEN). Dupont Cap invested in 0.01% or 7,861 shares. Eqis Capital Mngmt holds 25,171 shares. Pnc Fin Group, a Pennsylvania-based fund reported 28,404 shares. Tredje AP fonden lifted its holdings in Seattle Genetics by 3.7% in the second quarter. According to the latest data, the consensus recommendation for Seattle Genetics, Inc. (NASDAQ:USLM). Blackrock, New York-based fund reported 166,606 shares. DRW Securities LLC bought a new stake in shares of Seattle Genetics during the second quarter valued at approximately $207,000. (NASDAQ:SGEN) or 6,377 shares. Analysts have placed a $64.57 price target on Seattle Genetics, Inc., suggesting a 24.7% gain from recent close. (NASDAQ:USLM) for 1,525 shares. 1,432 are held by Clearbridge Invs Ltd Liability Co. Mason Street Advisors Ltd Liability Co stated it has 20,326 shares. Lyon Street Cap Limited Com owns 83,506 shares. (NASDAQ:CUTR). Product Ptnrs Ltd reported 0.06% of its portfolio in Cutera, Inc.

Like this: